Trial
NCT01113541
One-Year Trial of Oral Ziprasidone in Bipolar Patients With Metabolic Syndrome
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Collaborators
—
Condition
Bipolar Disorder
Intervention
Ziprasidone HCL (oral)
Why stopped
See termination reason in detailed description.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-03-03